Lu S - Search Results

1

Androgen receptor induces EPHA3 expression by interacting with transcription factor SP1.

Diao X, Chen X, Pi Y, Zhang Y, Wang F, Liu P, Gao Y, Wang X, Yang S, Lu S. Diao X, et al. Among authors: lu s. Oncol Rep. 2018 Aug;40(2):1174-1184. doi: 10.3892/or.2018.6503. Epub 2018 Jun 18. Oncol Rep. 2018. PMID: 29917167

2

MT1-MMP Inhibits the Activity of Bst-2 via Their Cytoplasmic Domains Dependent Interaction.

Fan L, Liu L, Zhu C, Zhu Q, Lu S, Liu P. Fan L, et al. Among authors: lu s. Int J Mol Sci. 2016 May 26;17(6):818. doi: 10.3390/ijms17060818. Int J Mol Sci. 2016. PMID: 27240342 Free PMC article.

3

Isorhapontigenin induced cell growth inhibition and apoptosis by targeting EGFR-related pathways in prostate cancer.

Zhu C, Zhu Q, Wu Z, Yin Y, Kang D, Lu S, Liu P. Zhu C, et al. Among authors: lu s. J Cell Physiol. 2018 Feb;233(2):1104-1119. doi: 10.1002/jcp.25968. Epub 2017 May 24. J Cell Physiol. 2018. PMID: 28422286

4

CXCL13 is androgen-responsive and involved in androgen induced prostate cancer cell migration and invasion.

Fan L, Zhu Q, Liu L, Zhu C, Huang H, Lu S, Liu P. Fan L, et al. Among authors: lu s. Oncotarget. 2017 Jun 7;8(32):53244-53261. doi: 10.18632/oncotarget.18387. eCollection 2017 Aug 8. Oncotarget. 2017. PMID: 28881808 Free PMC article.

5

Traditional Chinese Medicine CFF-1 induced cell growth inhibition, autophagy, and apoptosis via inhibiting EGFR-related pathways in prostate cancer.

Wu Z, Zhu Q, Yin Y, Kang D, Cao R, Tian Q, Zhang Y, Lu S, Liu P. Wu Z, et al. Among authors: lu s. Cancer Med. 2018 Apr;7(4):1546-1559. doi: 10.1002/cam4.1419. Epub 2018 Mar 13. Cancer Med. 2018. PMID: 29533017 Free PMC article.

6

EGFR‑associated pathways involved in traditional Chinese medicine (TCM)‑1‑induced cell growth inhibition, autophagy and apoptosis in prostate cancer.

Wu Z, Zhu Q, Zhang Y, Yin Y, Kang D, Cao R, Tian Q, Lu S, Liu P. Wu Z, et al. Among authors: lu s. Mol Med Rep. 2018 Jun;17(6):7875-7885. doi: 10.3892/mmr.2018.8818. Epub 2018 Mar 28. Mol Med Rep. 2018. PMID: 29620175

7

AZGP1 is androgen responsive and involved in AR-induced prostate cancer cell proliferation and metastasis.

Cao R, Ke M, Wu Q, Tian Q, Liu L, Dai Z, Lu S, Liu P. Cao R, et al. Among authors: lu s. J Cell Physiol. 2019 Aug;234(10):17444-17458. doi: 10.1002/jcp.28366. Epub 2019 Feb 28. J Cell Physiol. 2019. PMID: 30820960

8

P21 and P27 promote tumorigenesis and progression via cell cycle acceleration in seminal vesicles of TRAMP mice.

Li T, Wang F, Dang Y, Dong J, Zhang Y, Zhang C, Liu P, Gao Y, Wang X, Yang S, Lu S. Li T, et al. Among authors: lu s. Int J Biol Sci. 2019 Aug 19;15(10):2198-2210. doi: 10.7150/ijbs.35092. eCollection 2019. Int J Biol Sci. 2019. PMID: 31592235 Free PMC article.

9

NCAPD3 promotes prostate cancer progression by up-regulating EZH2 and MALAT1 through STAT3 and E2F1.

Jing Z, Liu Q, Xie W, Wei Y, Liu J, Zhang Y, Zuo W, Lu S, Zhu Q, Liu P. Jing Z, et al. Among authors: lu s. Cell Signal. 2022 Apr;92:110265. doi: 10.1016/j.cellsig.2022.110265. Epub 2022 Jan 24. Cell Signal. 2022. PMID: 35085770

10

Traditional Chinese medicine CFF-1 exerts a potent anti-tumor immunity to hinder tumor growth and metastasis in prostate cancer through EGFR/JAK1/STAT3 pathway to inhibit PD-1/PD-L1 checkpoint signaling.

Zhang Y, Wei Y, Jiang S, Dang Y, Yang Y, Zuo W, Zhu Q, Liu P, Gao Y, Lu S. Zhang Y, et al. Among authors: lu s. Phytomedicine. 2022 May;99:153939. doi: 10.1016/j.phymed.2022.153939. Epub 2022 Jan 14. Phytomedicine. 2022. PMID: 35172257

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

17,026 results

Search Page

Filters